Equity Capital Markets

Company · CIK 1709401

Rubius Therapeutics, Inc.

CIK1709401 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
Listedno ticker on SEC record today
First annual or quarterly report2018-08-31

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-265482
ShelfWithdrawn
 2022-06-082023-02-223
333-232955
ShelfEffective
 2019-08-012021-03-184
333-225840
IPOFinal prospectus
 2018-06-222018-07-185

Filings

13
FiledFilingRegistrationAccession
2023-02-22RWWithdrawn 333-2654820001104659-23-024021
2022-06-21EFFECTDeclared effective 333-2654829999999995-22-001831
2022-06-08S-3Shelf registered 333-2654820001104659-22-069304
2021-03-18424B5Shelf takedown 333-2329550001104659-21-038061
2021-03-15424B5Shelf takedown 333-2329550001104659-21-036395
2019-08-21EFFECTDeclared effective 333-2329559999999995-19-001940
2019-08-01S-3Shelf registered 333-2329550001047469-19-004493
2018-07-18424B4Final prospectus 333-2258400001047469-18-005073
2018-07-17EFFECTDeclared effective 333-2258409999999995-18-001813
2018-07-09S-1/AAmendment 333-2258400001047469-18-004887
2018-07-02S-1/AAmendment 333-2258400001047469-18-004849
2018-06-22S-1Registration filed 333-2258400001047469-18-004710
2018-04-13DRSDraft made public 377-020210000912057-18-000178

All filings of this company · CSV